Adam Fabisiak

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Gastroesophageal Reflux Disease

Top Venues

Journal of clinical medicine

Diagnostics (Basel, Switzerland)

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Dobek, Mateusz Kobierecki, Konrad Kosztowny, Oliwia Grząsiak, Adam Fabisiak, Krzysztof Falenta, Ludomir Stefańczyk
Utility of Contrast-Enhanced Ultrasound in Optimizing Hepatic Abscess Treatment and Monitoring. Journal of clinical medicine 13 (17) (2024)
Adam Dobek, Mateusz Kobierecki, Wojciech Ciesielski, Oliwia Grząsiak, Adam Fabisiak, Ludomir Stefańczyk
Usefulness of Contrast-Enhanced Ultrasound in the Differentiation between Hepatocellular Carcinoma and Benign Liver Lesions. Diagnostics (Basel, Switzerland) 13 (12) (2023)
Adam Dobek, Mateusz Kobierecki, Wojciech Ciesielski, Oliwia Grząsiak, Adam Fabisiak, Ludomir Stefańczyk
Usefulness of Contrast-Enhanced Ultrasound in the Differentiation between Hepatocellular Carcinoma and Benign Liver Lesions. Diagnostics (Basel, Switzerland) 13 (12) (2023)
Maria Wołyniak, Ewa Małecka-Panas, Marta Zielińska, Adam Fabisiak
A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis-Clinical Implications. Journal of clinical medicine 11 (22) (2022)
Agata Binienda, Adam Makaro, Marcin Talar, Julia B Krajewska, Aleksandra Tarasiuk, Adrian Bartoszek, Adam Fabisiak, Paula Mosińska, Karolina Niewinna, Katarzyna Dziedziczak, Mikołaj Świerczyński, Radzisław Kordek, Maciej Salaga, Jakub Fichna
Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis. Molecules (Basel, Switzerland) 26 (22) (2021)
Patrycja Dudek, Adam Fabisiak, Hubert Zatorski, Ewa Małecka-Panas, Renata Talar-Wojnarowska
Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment. Journal of clinical medicine 10 (23) (2021)
Maciej Salaga, Adrian Bartoszek, Agata Binienda, Julia B Krajewska, Adam Fabisiak, Paula Mosińska, Katarzyna Dziedziczak, Karolina Niewinna, Marcin Talar, Aleksandra Tarasiuk, Radzisław Kordek, Jakub Fichna
Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice. Nutrients 13 (8) (2021)
Adam Fabisiak, Adrian Bartoszek, Marcin Talar, Agata Binienda, Katarzyna Dziedziczak, Julia B Krajewska, Paula Mosińska, Karolina Niewinna, Aleksandra Tarasiuk, Anna Mokrowiecka, Agnieszka Wierzchniewska-Ławska, Ewa Małecka-Panas, Maciej Salaga, Jakub Fichna
Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease. Journal of clinical medicine 9 (12) (2020)
Adam Fabisiak, Natalia Fabisiak, Anna Mokrowiecka, Ewa Malecka-Panas, Damian Jacenik, Radzislaw Kordek, Marta Zielinska, Katarzyna Kieć-Kononowicz, Jakub Fichna
Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 33 (3) (2020)
Adam Fabisiak, Małgorzata Sobocińska, Elżbieta Kamysz, Jakub Fichna, Marta Zielińska
Antinociceptive potency of enkephalins and enkephalinase inhibitors in the mouse model of colorectal distension-proof-of-concept. Chemical biology & drug design 92 (1) (2018)